ETF overview
The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U.S. biotechnology sector.
Current price
211.55 USD+0.50%
Close 21 Oct 2026Interval
BenchmarksFund facts
- Expense ratio
- 0.44%
- Fund assets
- 10.86B USD (all share classes)
- Issuer
- iShares
- Inception date
- Feb 5, 2001
- Number of holdings
- 243
Breakdown
Holdings (243)
| Name | Ticker | Weight |
|---|---|---|
| GILEAD SCIENCES | GILD | 8.66% |
| AMGEN INC | AMGN | 8.12% |
| VERTEX PHARMACEUTICALS | VRTX | 7.52% |
| MODERNA | MRNA | 6.15% |
| REGENERON PHARMACEUTICALS | REGN | 5.62% |
| NATERA | NTRA | 3.88% |
| ARGENX SE ADR | ARGX | 3.35% |
| ILLUMINA INC | ILMN | 2.87% |
| REVOLUTION MEDICINES | RVMD | 2.60% |
| BIOGEN | BIIB | 2.46% |
| and 230 more | ||
Similar ETFs
- Invesco Nasdaq Biotechnology ETFIBBQ · Overlap 86% · Expense ratio 0.19%
- Invesco NASDAQ Biotech UCITS ETFSBIO.L · Overlap 86% · Expense ratio 0.40%
- iShares Nasdaq US Biotechnology UCITS ETFBTEC.L · Overlap 86% · Expense ratio 0.35%
- MiraeAsset TIGER NASDAQ BIO ETF203780.KS · Overlap 86% · Expense ratio 0.30%
- VanEck Biotech ETFBBH · Overlap 65% · Expense ratio 0.35%
- First Trust NYSE Arca Biotechnology Index FundFBT · Overlap 44% · Expense ratio 0.55%
- State Street SPDR S&P Biotech ETFXBI · Overlap 44% · Expense ratio 0.35%
- Invesco Biotechnology & Genome ETFPBE · Overlap 43% · Expense ratio 0.59%
Overlap is the share of assets the two funds hold in common.
Historical returns do not guarantee future returns. This is not investment advice.
Benchmarks
Fund facts
- Expense ratio
- 0.44%
- Fund assets
- 10.86B USD (all share classes)
- Issuer
- iShares
- Inception date
- Feb 5, 2001
- Number of holdings
- 243
Breakdown
Holdings (243)
| Name | Ticker | Weight |
|---|---|---|
| GILEAD SCIENCES | GILD | 8.66% |
| AMGEN INC | AMGN | 8.12% |
| VERTEX PHARMACEUTICALS | VRTX | 7.52% |
| MODERNA | MRNA | 6.15% |
| REGENERON PHARMACEUTICALS | REGN | 5.62% |
| NATERA | NTRA | 3.88% |
| ARGENX SE ADR | ARGX | 3.35% |
| ILLUMINA INC | ILMN | 2.87% |
| REVOLUTION MEDICINES | RVMD | 2.60% |
| BIOGEN | BIIB | 2.46% |
| and 230 more | ||
ETF overview
The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U.S. biotechnology sector.
- Invesco Nasdaq Biotechnology ETFIBBQ · Overlap 86% · Expense ratio 0.19%
- Invesco NASDAQ Biotech UCITS ETFSBIO.L · Overlap 86% · Expense ratio 0.40%
- iShares Nasdaq US Biotechnology UCITS ETFBTEC.L · Overlap 86% · Expense ratio 0.35%
- MiraeAsset TIGER NASDAQ BIO ETF203780.KS · Overlap 86% · Expense ratio 0.30%
- VanEck Biotech ETFBBH · Overlap 65% · Expense ratio 0.35%
- First Trust NYSE Arca Biotechnology Index FundFBT · Overlap 44% · Expense ratio 0.55%
- State Street SPDR S&P Biotech ETFXBI · Overlap 44% · Expense ratio 0.35%
- Invesco Biotechnology & Genome ETFPBE · Overlap 43% · Expense ratio 0.59%
Overlap is the share of assets the two funds hold in common.
Unlock all ETF data
Sign up for FreeUnlock all ETF data
Sign up for Free